Chemical Compound

(7S,9S)-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-Naphthacenedione; [7S-[7a,9a,9(R*)]]-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-5,12-Naphthacenedione; 13-Dihydroidarubicin; 4-Demethoxydaunorubicinol; Antibiotic FCE 22723;

CAS Registry Number 86189-66-4
返回搜索 申请报价
(7S,9S)-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-Naphthacenedione; [7S-[7a,9a,9(R*)]]-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-5,12-Naphthacenedione; 13-Dihydroidarubicin; 4-Demethoxydaunorubicinol; Antibiotic FCE 22723; 结构式
Primary record

(7S,9S)-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-Naphthacenedione; [7S-[7a,9a,9(R*)]]-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-5,12-Naphthacenedione; 13-Dihydroidarubicin; 4-Demethoxydaunorubicinol; Antibiotic FCE 22723;

库存
1,002 克
纯度
99.2 %
CAS
86189-66-4

化合物标识与属性

CAS
86189-66-4
PubChem CID
21118312
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)([C@H](C)O)O)N)O
Canonical SMILES
C[C@@H]1O[C@@H](O[C@H]2C[C@](O)([C@H](C)O)Cc3c(O)c4c(c(O)c32)C(=O)c2ccccc2C4=O)C[C@H](N)[C@@H]1O

名称与同义词

  • Idarubicinol
  • 13-dihydroidarubicin
  • (13S)-Idarubicinol
  • 4-Demethoxydaunorubicinol
  • RefChem:923286
  • Z3GYR877XQ
  • Antibiotic FCE 22723
  • 4-demethoxy-14-hydroxydaunorubicin
  • SCHEMBL13147738
  • 86189-66-4
  • CHEBI:197279
  • KMIBSUUWQWSRQV-KESCCHOKSA-N
  • DTXSID701006632
  • C26-H29-N-O9
  • ZINC60184044
  • NSC 256439
  • Idarubicinol (Mixture of Diastereomers)
  • CID:21118312
  • SID:144087473
  • J350.490E
  • C054440
  • idarubicinol, (7S-(7alpha,9alpha,9(S*)))-isomer
  • (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-8,10-dihydro-7H-tetracene-5,12-dione
  • (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-tridesoxy-alpha-L-hexopyranosid
  • (7S)-7beta-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-9alpha-[(S)-1-hydroxyethyl]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione
  • (7S,9S)-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-Naphthacenedione; [7S-[7a,9a,9(R*)]]-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-5,12-Naphthacenedione; 13-Dihydroidarubicin; 4-Demethoxydaunorubicinol; Antibiotic FCE 22723;
  • (7S,9S)-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1R*)-1-hydroxyethyl]-5,12-Naphthacenedione
  • (7S,9S)-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
  • (9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-8,10-dihydro-7H-tetracene-5,12-dione
  • 4-Demethoxydaunorubicinol; Antibiotic FCE 22723; (7S,9S)-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-9-((S)-1-hydroxyethyl)-7,8,9,10-tetrahydrotetracene-5,12-dione
  • 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-, (7S,9S)-